News Releases

August 7, 2019 at 4:01 PM EDT

Summary Toggle OptimizeRx Reports Record Second Quarter 2019 Results; Total Revenue Up 37% to $7.0 Million, Net Income up 45% to $407,000 or $0.03 per Diluted Share

ROCHESTER, Mich. , Aug. 07, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the second quarter ended June 30, 2019 . Quarterly comparisons are to the same year-ago quarter.

PDF Version
July 24, 2019 at 4:01 PM EDT

Summary Toggle OptimizeRx Sets Second Quarter 2019 Conference Call for Wednesday, August 7, 2019 at 4:30 p.m. ET

ROCHESTER, Mich. , July 24, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, will hold a conference call on Wednesday, August 7, 2019 at 4:30 p.m. Eastern time to discuss results for the second quarter ended

PDF Version
July 23, 2019 at 8:31 AM EDT

Summary Toggle OptimizeRx Establishes Direct Partnership and Integration with NextGen Healthcare

More Than 55,000 Prescribers on the NextGen® Enterprise Network Will Have Immediate Access to OptimizeRx’s Point-of-Care Platform That Links the Pharma-Physician-Patient-Payor Continuum ROCHESTER, Mich. , July 23, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp.

PDF Version
June 25, 2019 at 8:31 AM EDT

Summary Toggle OptimizeRx Set to Join Russell Microcap® and 3000® Indexes

ROCHESTER, Mich. , June 25, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX) , a leading platform for digital health messaging in the pharmaceutical industry, is expected to join the Russell Microcap ® and 3000 ® Indexes at the conclusion of the 2019 Russell indexes annual reconstitution,

PDF Version
June 12, 2019 at 8:31 AM EDT

Summary Toggle OptimizeRx to Participate at the 5th Annual ROTH London Conference on June 17-19, 2019

ROCHESTER, Mich. , June 12, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has been invited to participate in the ROTH London Conference being held on June 17-19, 2019 at the Dorchester Hotel in London, U.K.

PDF Version
June 10, 2019 at 8:31 AM EDT

Summary Toggle OptimizeRx Launches New Growth Phase Immediately Following Addition of Chief Commercial Officer

Todd Samuelson, Eze Abosi and Adam Sokol Bring more than 40 Years' Experience in Enterprise Solution Sales and Relationship Management in Healthcare, Combined with Commercialization of HCP and Patient-Centric Innovative Solutions ROCHESTER, Mich. , June 10, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp.

PDF Version
June 5, 2019 at 8:50 AM EDT

Summary Toggle OptimizeRx Announces Pricing of Public Offering of Common Stock

ROCHESTER, Mich. , June 05, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering of 1,538,500 shares of its common stock,

PDF Version
June 4, 2019 at 4:01 PM EDT

Summary Toggle OptimizeRx Announces Proposed Public Offering of Common Stock

ROCHESTER, Mich. , June 04, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced a proposed underwritten public offering of shares of its common stock. In connection with the offering,

PDF Version
May 31, 2019 at 10:30 AM EDT

Summary Toggle OptimizeRx to Participate at Investor Conferences in June

ROCHESTER, Mich. , May 31, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate in two investor conferences being held in June. Event: William Blair & Company 39 th Annual Growth

PDF Version
May 8, 2019 at 4:01 PM EDT

Summary Toggle OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $833,000 or $0.06 per Diluted Share

ROCHESTER, Mich. , May 08, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the first quarter ended March 31, 2019 . Quarterly comparisons are to the same year-ago quarter.

PDF Version